Richard Press - Publications

Oregon Health and Science University, Portland, OR 

77 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Anekpuritanang T, Klairmont MM, Gradowski J, Hagiwara K, Bailey NG, Chandra PK, Liu Y, Mulder HL, Easton J, Zhang J, Martin MG, Owczarczyk AB, Dunlap J, Fan G, Press RD, et al. In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported. Blood Advances. PMID 34559205 DOI: 10.1182/bloodadvances.2021004983  1
2021 Shomali W, Damnernsawad A, Theparee T, Sampson D, Morrow Q, Yang F, Fernandez-Pol S, Press RD, Zehnder JL, Tyner JW, Gotlib JR. A novel activating JAK1 mutation in chronic eosinophilic leukemia. Blood Advances. PMID 34496019 DOI: 10.1182/bloodadvances.2021004237  1
2021 Yang F, Long N, Anekpuritanang T, Bottomly D, Savage JC, Lee T, Solis-Ruiz JM, Borate U, Wilmot B, Tognon CE, Bock AM, Pollyea DA, Radhakrishnan SM, Radhakrishnan S, Patel PA, ... ... Press RD, et al. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult AML patients. Blood. PMID 34482403 DOI: 10.1182/blood.2021011354  1
2021 Tsumura AM, Druker BJ, Brewer D, Press R, Braun TP. BCR-ABL+ Chronic Myeloid Leukemia Arising in a Family With Inherited ANKRD26-Related Thrombocytopenia. Jco Precision Oncology. 5. PMID 34250402 DOI: 10.1200/PO.20.00318  1
2021 Newell LF, Dunlap J, Gatter K, Bagby GC, Press RD, Cook RJ, Fletcher L, Leonard JT, Leong KM, Bubalo JS, Olyaei A, Deloughery TG, Maziarz RT, Maynard E, Orloff SL, et al. Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 33961341 DOI: 10.1111/ajt.16635  1
2021 Newell LF, Williams T, Liu J, Yu Y, Chen Y, Booth GC, Knight RJ, Goslee KR, Cook RJ, Leonard J, Meyers G, Traer E, Press RD, Fan G, Wang Y, et al. Engrafted donor-derived clonal hematopoiesis after allogenic hematopoietic cell transplantation is associated with chronic GVHD requiring immunosuppressive therapy, but no adverse impact on OS or relapse. Transplantation and Cellular Therapy. PMID 33901720 DOI: 10.1016/j.jtct.2021.04.014  1
2020 Yang F, Akkari Y, Letaw J, Partain J, Wilson H, Blackwell D, Gonzales S, Lopetrone D, Press R. 68. Validation of CNA detection using an amplicon-based targeted NGS panel for hematological malignancies Cancer Genetics and Cytogenetics. 244: 26. DOI: 10.1016/J.Cancergen.2020.04.072  1
2020 Newell LF, Dunlap JB, Gatter K, Press R, Fan G, Cook R, Leonard JT, Maziarz RT, Maynard E, Orloff SL, Enestvedt CK. Graft-Versus-Host Disease after Solid Organ Transplant Is Frequently Associated with Bone Marrow Failure and Hemophagocytosis Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.762  1
2019 Dao KT, Gotlib J, Deininger MMN, Oh ST, Cortes JE, Collins RH, Winton EF, Parker DR, Lee H, Reister A, Schultz, Savage S, Stevens, Brockett C, Subbiah N, ... Press RD, et al. Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900895. PMID 31880950 DOI: 10.1200/Jco.19.00895  1
2019 Werstein B, Dunlap J, Cascio MJ, Ohgami RS, Fan G, Press R, Raess PW. Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival. The Journal of Molecular Diagnostics : Jmd. PMID 31866570 DOI: 10.1016/J.Jmoldx.2019.11.004  1
2019 Yang F, Anekpuritanang T, Press RD. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia. Molecular Diagnosis & Therapy. PMID 31848884 DOI: 10.1007/s40291-019-00443-9  1
2019 Stoner RC, Press RD, Maxson JE, Tyner JW, Dao KT. Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy. Leukemia. PMID 31844143 DOI: 10.1038/S41375-019-0688-1  1
2019 Dunlap JB, Leonard J, Rosenberg M, Cook R, Press R, Fan G, Raess P, Druker BJ, Traer E. The combination of NPM1, DNMT3A and IDH1/2 mutations leads to inferior overall survival in AML. American Journal of Hematology. PMID 31145495 DOI: 10.1002/Ajh.25517  1
2019 Press RD, Eickelberg G, Froman A, Yang F, Stentz A, Flatley EM, Fan G, Lim JY, Meyers G, Maziarz RT, Cook RJ. NGS-Defined Minimal Residual Disease Before Stem Cell Transplantation Predicts Acute Myeloid Leukemia Relapse. American Journal of Hematology. PMID 31124175 DOI: 10.1002/ajh.25514  1
2019 Brown JT, Beldorth IJ, Laosinchai-Wolf W, Fahey ME, Jefferson KL, Ruskin AK, Roth JJ, Cai L, Watt CD, Press RD, Yang F, Hedges JB, Andruss BF. Analytical validation of a highly sensitive, multiplexed chronic myeloid leukemia monitoring system targeting BCR-ABL1 RNA. The Journal of Molecular Diagnostics : Jmd. PMID 31026597 DOI: 10.1016/J.Jmoldx.2019.03.002  1
2019 Lucero OM, Parker K, Funk T, Dunlap J, Press R, Gardner RA, Chang BH. Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure. British Journal of Haematology. PMID 30810217 DOI: 10.1111/Bjh.15812  1
2018 Spiciarich DR, Oh ST, Foley A, Hughes SB, Mauro MJ, Abdel-Wahab O, Press RD, Viner R, Thompson SL, Chen Q, Azadi P, Bertozzi CR, Maxson JE. A novel germline variant in CSF3R reduces N-glycosylation and exerts potent oncogenic effects in leukemia. Cancer Research. PMID 30348809 DOI: 10.1158/0008-5472.Can-18-1638  1
2018 Alberti MO, Srivatsan SN, Shao J, McNulty SN, Chang GS, Miller CA, Dunlap JB, Yang F, Press RD, Gao Q, Ding L, Heusel JW, Duncavage EJ, Walter MJ. Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS. Leukemia. PMID 29959414 DOI: 10.1038/S41375-018-0193-Y  1
2017 Ma J, Dunlap J, Paliga A, Traer E, Press R, Shen L, Fan G. DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML. Leukemia & Lymphoma. 1-11. PMID 29165010 DOI: 10.1080/10428194.2017.1397659  1
2017 Ma L, Boucher JI, Paulsen J, Matuszewski S, Eide CA, Ou J, Eickelberg G, Press RD, Zhu LJ, Druker BJ, Branford S, Wolfe SA, Jensen JD, Schiffer CA, Green MR, et al. CRISPR-Cas9-mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy. Proceedings of the National Academy of Sciences of the United States of America. PMID 29078326 DOI: 10.1073/Pnas.1708268114  1
2017 Kaul KL, Sabatini LM, Tsongalis GJ, Caliendo AM, Olsen RJ, Ashwood ER, Bale S, Benirschke R, Carlow D, Funke BH, Grody WW, Hayden RT, Hegde M, Lyon E, Murata K, ... ... Press RD, et al. The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care. Academic Pathology. 4: 2374289517708309. PMID 28815200 DOI: 10.1177/2374289517708309  1
2016 Raess PW, Cascio MJ, Fan G, Press R, Druker BJ, Brewer D, Spurgeon SE. Concurrent STAT3, DNMT3A and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential. American Journal of Hematology. PMID 27761930 DOI: 10.1002/Ajh.24586  1
2016 Arora R, Press RD. Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices. Leukemia & Lymphoma. 1-9. PMID 27412040 DOI: 10.1080/10428194.2016.1190974  1
2016 Wiedmeier JE, Kato C, Zhang Z, Lee H, Dunlap J, Nutt E, Rattray R, McKay S, Eide C, Press R, Mori M, Druker B, Dao KH. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women. Experimental Hematology. PMID 27235757 DOI: 10.1016/J.Exphem.2016.05.009  1
2016 Reinig E, Yang F, Traer E, Arora R, Brown S, Rattray R, Braziel R, Fan G, Press R, Dunlap J. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia. American Journal of Clinical Pathology. PMID 27124934 DOI: 10.1093/Ajcp/Aqw016  1
2016 Press RD, Eickelberg G, McDonald TJ, Halley J, Long T, Tafe LJ, Weck KE. Highly accurate molecular genetic testing for HFE hereditary hemochromatosis: results from 10 years of blinded proficiency surveys by the College of American Pathologists. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27124787 DOI: 10.1038/gim.2016.34  0.01
2016 Cross NC, White HE, Ernst T, Welden L, Dietz C, Saglio G, Mahon FX, Wong CC, Zheng D, Wong S, Wang SS, Akiki S, Albano F, Andrikovics H, Anwar J, ... ... Press RD, et al. Development and evaluation of a secondary reference panel for BCR-ABL1 quantitation on the International Scale. Leukemia. PMID 27109508 DOI: 10.1038/Leu.2016.90  1
2016 Letaw J, Beadling C, Burchard J, Dahl C, Hadd A, Keck J, King D, Moore W, Neff T, Terrill M, Thanner J, Press R, Richards S, Corless C, Barney O. Sequence data analysis and the clinical genomics database F1000research. 5. DOI: 10.7490/F1000Research.1112591.1  1
2015 Garbati MR, Welgan CA, Landefeld SH, Newell LF, Agarwal A, Dunlap JB, Chourasia TK, Lee H, Elferich J, Traer E, Rattray R, Cascio MJ, Press RD, Bagby GC, Tyner JW, et al. Mutant calreticulin-expressing cells induce monocyte hyperreactivity through a paracrine mechanism. American Journal of Hematology. PMID 26573090 DOI: 10.1002/Ajh.24245  1
2015 Shi M, Spurgeon S, Press R, Olson S, Fan G. MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting. Annals of Hematology. 94: 1941-4. PMID 26231802 DOI: 10.1007/S00277-015-2460-6  1
2015 Hakki M, Rattray RM, Press RD. The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 68: 1-5. PMID 26071326 DOI: 10.1016/j.jcv.2015.04.012  0.01
2015 Lyon E, Cockerill FR, Bale SJ, Beadling C, Bry L, Hagenkord J, Kulkarni S, Press R, Palomaki GE. Next generation sequencing in clinical diagnostics: experiences of early adopters. Clinical Chemistry. 61: 41-9. PMID 25421800 DOI: 10.1373/Clinchem.2014.222687  1
2014 Dao KH, Solti MB, Maxson JE, Winton EF, Press RD, Druker BJ, Tyner JW. Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia. Leukemia Research Reports. 3: 67-9. PMID 25180155 DOI: 10.1016/J.Lrr.2014.07.002  1
2014 Zabriskie MS, Eide CA, Tantravahi SK, Vellore NA, Estrada J, Nicolini FE, Khoury HJ, Larson RA, Konopleva M, Cortes JE, Kantarjian H, Jabbour EJ, Kornblau SM, Lipton JH, Rea D, ... ... Press RD, et al. BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia. Cancer Cell. 26: 428-42. PMID 25132497 DOI: 10.1016/J.Ccr.2014.07.006  1
2014 Press RD. Clinical implementation of next-generation sequencing. Clinical Advances in Hematology & Oncology : H&O. 12: 263-5. PMID 25003357  0.01
2013 Luu MH, Press RD. BCR-ABL PCR testing in chronic myelogenous leukemia: molecular diagnosis for targeted cancer therapy and monitoring. Expert Review of Molecular Diagnostics. 13: 749-62. PMID 24063401 DOI: 10.1586/14737159.2013.835573  0.01
2013 Press RD, Kamel-Reid S, Ang D. BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemia. The Journal of Molecular Diagnostics : Jmd. 15: 565-76. PMID 23810242 DOI: 10.1016/J.Jmoldx.2013.04.007  0.01
2013 Moore FR, Yang F, Press RD. Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia. Methods in Molecular Biology (Clifton, N.J.). 999: 25-39. PMID 23666688 DOI: 10.1007/978-1-62703-357-2_2  1
2013 Moore FR, Rempfer CB, Press RD. Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemia. Methods in Molecular Biology (Clifton, N.J.). 999: 1-23. PMID 23666687 DOI: 10.1007/978-1-62703-357-2_1  1
2013 Ang D, Fan G, Traer E, Kovacsovics T, Leeborg N, Loriaux M, Warrick A, Beadling C, Olson S, Gatter K, Braziel RM, Corless CL, Press R, Dunlap J. Utility of Multiplex Mutation Analysis in the Diagnosis of Chronic Myelomonocytic Leukemia Journal of Leukemia. 1: 1-6. DOI: 10.4172/2329-6917.1000114  1
2012 Dunlap J, Beadling C, Warrick A, Neff T, Fleming WH, Loriaux M, Heinrich MC, Kovacsovics T, Kelemen K, Leeborg N, Gatter K, Braziel RM, Press R, Corless CL, Fan G. Multiplex high-throughput gene mutation analysis in acute myeloid leukemia. Human Pathology. 43: 2167-76. PMID 22658276 DOI: 10.1016/J.Humpath.2012.03.002  1
2011 O'Hare T, Zabriskie MS, Eide CA, Agarwal A, Adrian LT, You H, Corbin AS, Yang F, Press RD, Rivera VM, Toplin J, Wong S, Deininger MW, Druker BJ. The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia. Blood. 118: 5250-4. PMID 21908430 DOI: 10.1182/Blood-2011-05-349191  1
2011 Fleischman AG, Aichberger KJ, Luty SB, Bumm TG, Petersen CL, Doratotaj S, Vasudevan KB, LaTocha DH, Yang F, Press RD, Loriaux MM, Pahl HL, Silver RT, Agarwal A, O'Hare T, et al. TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms. Blood. 118: 6392-8. PMID 21860020 DOI: 10.1182/Blood-2011-04-348144  1
2011 Dunlap J, Kelemen K, Leeborg N, Braziel R, Olson S, Press R, Huang J, Gatter K, Loriaux M, Fan G. Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms. American Journal of Clinical Pathology. 135: 709-19. PMID 21502425 DOI: 10.1309/Ajcps6C8Evycqnrm  1
2010 White HE, Matejtschuk P, Rigsby P, Gabert J, Lin F, Lynn Wang Y, Branford S, Müller MC, Beaufils N, Beillard E, Colomer D, Dvorakova D, Ehrencrona H, Goh HG, El Housni H, ... ... Press RD, et al. Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. Blood. 116: e111-7. PMID 20720184 DOI: 10.1182/Blood-2010-06-291641  1
2010 Press RD. Major molecular response in CML patients treated with tyrosine kinase inhibitors: the paradigm for monitoring targeted cancer therapy. The Oncologist. 15: 744-9. PMID 20566700 DOI: 10.1634/theoncologist.2010-0055  0.01
2010 Sherbenou DW, Hantschel O, Kaupe I, Willis S, Bumm T, Turaga LP, Lange T, Dao KH, Press RD, Druker BJ, Superti-Furga G, Deininger MW. BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib. Blood. 116: 3278-85. PMID 20519627 DOI: 10.1182/Blood-2008-10-183665  1
2009 Barton JC, Lafreniere SA, Leiendecker-Foster C, Li H, Acton RT, Press RD, Eckfeldt JH. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants. American Journal of Hematology. 84: 710-4. PMID 19787796 DOI: 10.1002/ajh.21524  1
2009 Press RD, Willis SG, Laudadio J, Mauro MJ, Deininger MW. Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib. Blood. 114: 2598-605. PMID 19625707 DOI: 10.1182/blood-2008-08-173674  1
2009 Wolff DJ, Heaney DL, Neuwald PD, Stellrecht KA, Press RD. Multi-Site PCR-based CMV viral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the association for molecular pathology. The Journal of Molecular Diagnostics : Jmd. 11: 87-92. PMID 19225134 DOI: 10.2353/jmoldx.2009.080097  1
2009 Jones D, Kamel-Reid S, Bahler D, Dong H, Elenitoba-Johnson K, Press R, Quigley N, Rothberg P, Sabath D, Viswanatha D, Weck K, Zehnder J. Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology. The Journal of Molecular Diagnostics : Jmd. 11: 4-11. PMID 19095773 DOI: 10.2353/Jmoldx.2009.080095  1
2008 Branford S, Fletcher L, Cross NC, Müller MC, Hochhaus A, Kim DW, Radich JP, Saglio G, Pane F, Kamel-Reid S, Wang YL, Press RD, Lynch K, Rudzki Z, Goldman JM, et al. Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood. 112: 3330-8. PMID 18684859 DOI: 10.1182/Blood-2008-04-150680  1
2008 Laudadio J, Deininger MW, Mauro MJ, Druker BJ, Press RD. An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy. The Journal of Molecular Diagnostics : Jmd. 10: 177-80. PMID 18276770 DOI: 10.2353/Jmoldx.2008.070128  1
2008 Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, Eckfeldt JH, McLaren CE, Reiss JA, McLaren GD, Reboussin DM, Gordeuk VR, Speechley MR, Press RD, Dawkins FW. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening. American Journal of Hematology. 83: 126-32. PMID 17726683 DOI: 10.1002/ajh.21053  1
2007 Adams PC, Reboussin DM, Press RD, Barton JC, Acton RT, Moses GC, Leiendecker-Foster C, McLaren GD, Dawkins FW, Gordeuk VR, Lovato L, Eckfeldt JH. Biological variability of transferrin saturation and unsaturated iron-binding capacity. The American Journal of Medicine. 120: 999.e1-7. PMID 17976429 DOI: 10.1016/j.amjmed.2007.02.027  1
2007 Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, Eckfeldt JH, McLaren CE, Reboussin DM, Gordeuk VR, Speechley MR, Reiss JA, Press RD, Dawkins FW. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening. Genetic Testing. 11: 269-75. PMID 17949288 DOI: 10.1089/gte.2007.0003  1
2007 Press RD, Galderisi C, Yang R, Rempfer C, Willis SG, Mauro MJ, Druker BJ, Deininger MW. A half-log increase in BCR-ABL RNA predicts a higher risk of relapse in patients with chronic myeloid leukemia with an imatinib-induced complete cytogenetic response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6136-43. PMID 17947479 DOI: 10.1158/1078-0432.Ccr-07-1112  1
2007 Müller MC, Saglio G, Lin F, Pfeifer H, Press RD, Tubbs RR, Paschka P, Gottardi E, O'Brien SG, Ottmann OG, Stockinger H, Wieczorek L, Merx K, König H, Schwindel U, et al. An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. Haematologica. 92: 970-3. PMID 17606448 DOI: 10.3324/haematol.11172  1
2007 Acton RT, Snively BM, Barton JC, McLaren CE, Adams PC, Rich SS, Eckfeldt JH, Press RD, Sholinsky P, Leiendecker-Foster C, McLaren GD, Speechley MR, Harris EL, Dawkins FW, Gordeuk VR, et al. A genome-wide linkage scan for iron phenotype quantitative trait loci: the HEIRS Family Study. Clinical Genetics. 71: 518-29. PMID 17539901 DOI: 10.1111/j.1399-0004.2007.00804.x  1
2007 Rivers CA, Barton JC, Gordeuk VR, Acton RT, Speechley MR, Snively BM, Leiendecker-Foster C, Press RD, Adams PC, McLaren GD, Dawkins FW, McLaren CE, Reboussin DM. Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells, Molecules & Diseases. 38: 247-52. PMID 17276706 DOI: 10.1016/j.bcmd.2006.12.002  1
2007 Sherbenou DW, Wong MJ, Humayun A, McGreevey LS, Harrell P, Yang R, Mauro M, Heinrich MC, Press RD, Druker BJ, Deininger MW. Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib. Leukemia. 21: 489-93. PMID 17252009 DOI: 10.1038/Sj.Leu.2404554  1
2006 Press RD, Love Z, Tronnes AA, Yang R, Tran T, Mongoue-Tchokote S, Mori M, Mauro MJ, Deininger MW, Druker BJ. BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML. Blood. 107: 4250-6. PMID 16467199 DOI: 10.1182/Blood-2005-11-4406  1
2005 Adams PC, Reboussin DM, Leiendecker-Foster C, Moses GC, McLaren GD, McLaren CE, Dawkins FW, Kasvosve I, Acton RT, Barton JC, Zaccaro D, Harris EL, Press R, Chang H, Eckfeldt JH. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study. Clinical Chemistry. 51: 1048-52. PMID 15833784 DOI: 10.1373/Clinchem.2005.048371  1
2004 Sekhon HS, Press RD, Schmidt WA, Hawley M, Rader A. Identification of cytomegalovirus in a liquid-based gynecologic sample using morphology, immunohistochemistry, and DNA real-time PCR detection. Diagnostic Cytopathology. 30: 411-7. PMID 15176029 DOI: 10.1002/dc.20048  1
2004 Hong KM, Najjar H, Hawley M, Press RD. Quantitative real-time PCR with automated sample preparation for diagnosis and monitoring of cytomegalovirus infection in bone marrow transplant patients. Clinical Chemistry. 50: 846-56. PMID 15010424 DOI: 10.1373/clinchem.2003.026484  1
2002 Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders Archives of Pathology and Laboratory Medicine. 126: 1304-1318. PMID 12421138  1
2001 Press R. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Molecular Diagnosis. 6: 212-213. DOI: 10.1054/Modi.2001.26156  0.01
1998 Cotler SJ, Bronner MP, Press RD, Carlson TH, Perkins JD, Emond MJ, Kowdley KV. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. Journal of Hepatology. 29: 257-62. PMID 9722207 DOI: 10.1016/S0168-8278(98)80011-1  1
1998 Press RD, Flora K, Gross C, Rabkin JM, Corless CL. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis. American Journal of Clinical Pathology. 109: 577-84. PMID 9576576 DOI: 10.1093/AJCP/109.5.577  1
1998 Egan RA, Kuyl JM, Press R, Lutsep HL. Lack of prothrombin gene mutation in young stroke patients Journal of Stroke & Cerebrovascular Diseases. 9: 229-231. DOI: 10.1053/Jscd.2000.16187  0.01
1996 Deloughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor LM, Press RD. Common mutation in methylenetetrahydrofolate reductase: Correlation with homocysteine metabolism and late-onset vascular disease Circulation. 94: 3074-3078. PMID 8989110 DOI: 10.1161/01.CIR.94.12.3074  1
1996 Flora K, Schiele M, Benner K, Montanaro A, Johnston W, Whitham R, Press R. An Outbreak of Acute Hepatitis C Among Recipients of Intravenous Immunoglobulin Annals of Allergy Asthma & Immunology. 76: 160-162. PMID 8595535 DOI: 10.1016/S1081-1206(10)63416-3  0.01
1996 Press RD, Liu XY, Beamer N, Coull BM. Ischemic stroke in the elderly: Role of the common factor V mutation causing resistance to activated protein C Stroke. 27: 44-48. PMID 8553401 DOI: 10.1161/01.STR.27.1.44  1
1994 Press RD, Reddy EP, Ewert DL. Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: A novel nonhematopoietic target cell for the myb oncogene Molecular and Cellular Biology. 14: 2278-2290. PMID 8139533 DOI: 10.1128/mcb.14.4.2278-2290.1994  1
1989 Press RD, Misra A, Samols D, Goldthwait DA, Mapstone TB. Major structural alterations of the c-sis gene are not observed in a series of tumors of the human central nervous system. Journal of Neuro-Oncology. 7: 345-56. PMID 2585029 DOI: 10.1007/Bf02147092  0.52
1989 Press R, Wilding P. Effect of glycation of low-density lipoprotein on the immunological determination of apolipoprotein B. Clinical Chemistry. 35: 2219-2223. DOI: 10.1093/Clinchem/35.11.2219  0.01
1988 Press RD, Samols D, Goldthwait DA. Expression and stability of c-sis mRNA in human glioblastoma cells. Biochemistry. 27: 5736-41. PMID 3052584 DOI: 10.1021/Bi00415A051  0.52
Show low-probability matches.